nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCG2—lung cancer	0.213	0.706	CbGaD
Rilpivirine—ABCB1—lung cancer	0.0886	0.294	CbGaD
Rilpivirine—NR1I2—Erlotinib—lung cancer	0.0694	0.128	CbGbCtD
Rilpivirine—NR1I2—Paclitaxel—lung cancer	0.0636	0.118	CbGbCtD
Rilpivirine—NR1I2—Docetaxel—lung cancer	0.046	0.085	CbGbCtD
Rilpivirine—SLCO1B3—Paclitaxel—lung cancer	0.0249	0.0461	CbGbCtD
Rilpivirine—ABCG2—Topotecan—lung cancer	0.0233	0.0431	CbGbCtD
Rilpivirine—ABCG2—Gefitinib—lung cancer	0.0213	0.0394	CbGbCtD
Rilpivirine—ABCG2—Teniposide—lung cancer	0.0207	0.0382	CbGbCtD
Rilpivirine—SLCO1B3—Docetaxel—lung cancer	0.018	0.0334	CbGbCtD
Rilpivirine—SLCO1B1—Irinotecan—lung cancer	0.0143	0.0265	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—lung cancer	0.013	0.0241	CbGbCtD
Rilpivirine—ABCG2—Erlotinib—lung cancer	0.0126	0.0233	CbGbCtD
Rilpivirine—ABCG2—Paclitaxel—lung cancer	0.0115	0.0213	CbGbCtD
Rilpivirine—ABCG2—Irinotecan—lung cancer	0.0114	0.0211	CbGbCtD
Rilpivirine—CYP2C19—Gefitinib—lung cancer	0.00952	0.0176	CbGbCtD
Rilpivirine—ABCG2—Cisplatin—lung cancer	0.00928	0.0172	CbGbCtD
Rilpivirine—CYP2C19—Teniposide—lung cancer	0.00924	0.0171	CbGbCtD
Rilpivirine—ABCG2—Etoposide—lung cancer	0.00911	0.0169	CbGbCtD
Rilpivirine—ABCB1—Topotecan—lung cancer	0.0084	0.0155	CbGbCtD
Rilpivirine—ABCG2—Docetaxel—lung cancer	0.00834	0.0154	CbGbCtD
Rilpivirine—CYP2B6—Irinotecan—lung cancer	0.008	0.0148	CbGbCtD
Rilpivirine—ABCB1—Gefitinib—lung cancer	0.00768	0.0142	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—lung cancer	0.00758	0.014	CbGbCtD
Rilpivirine—CYP2B6—Cisplatin—lung cancer	0.00652	0.0121	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—lung cancer	0.00622	0.0115	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—lung cancer	0.00602	0.0111	CbGbCtD
Rilpivirine—ABCB1—Vinorelbine—lung cancer	0.00592	0.011	CbGbCtD
Rilpivirine—CYP1A2—Erlotinib—lung cancer	0.0052	0.00961	CbGbCtD
Rilpivirine—CYP3A4—Topotecan—lung cancer	0.00503	0.00931	CbGbCtD
Rilpivirine—ABCB1—Crizotinib—lung cancer	0.00471	0.00871	CbGbCtD
Rilpivirine—CYP3A4—Gefitinib—lung cancer	0.0046	0.00852	CbGbCtD
Rilpivirine—ABCB1—Gemcitabine—lung cancer	0.0046	0.00852	CbGbCtD
Rilpivirine—ABCB1—Erlotinib—lung cancer	0.00454	0.00841	CbGbCtD
Rilpivirine—CYP3A4—Teniposide—lung cancer	0.00446	0.00826	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—lung cancer	0.00437	0.00809	CbGbCtD
Rilpivirine—ABCB1—Paclitaxel—lung cancer	0.00416	0.0077	CbGbCtD
Rilpivirine—ABCB1—Irinotecan—lung cancer	0.0041	0.00759	CbGbCtD
Rilpivirine—CYP1A2—Etoposide—lung cancer	0.00376	0.00695	CbGbCtD
Rilpivirine—ABCB1—Vinblastine—lung cancer	0.00365	0.00675	CbGbCtD
Rilpivirine—CYP3A4—Vinorelbine—lung cancer	0.00355	0.00656	CbGbCtD
Rilpivirine—ABCB1—Cisplatin—lung cancer	0.00334	0.00619	CbGbCtD
Rilpivirine—ABCB1—Etoposide—lung cancer	0.00329	0.00608	CbGbCtD
Rilpivirine—ABCB1—Docetaxel—lung cancer	0.00301	0.00556	CbGbCtD
Rilpivirine—CYP3A4—Crizotinib—lung cancer	0.00282	0.00522	CbGbCtD
Rilpivirine—CYP3A4—Erlotinib—lung cancer	0.00272	0.00504	CbGbCtD
Rilpivirine—CYP3A4—Paclitaxel—lung cancer	0.00249	0.00461	CbGbCtD
Rilpivirine—CYP3A4—Irinotecan—lung cancer	0.00246	0.00455	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—lung cancer	0.00224	0.00415	CbGbCtD
Rilpivirine—CYP3A4—Vinblastine—lung cancer	0.00219	0.00404	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—lung cancer	0.00217	0.00402	CbGbCtD
Rilpivirine—CYP3A4—Etoposide—lung cancer	0.00197	0.00364	CbGbCtD
Rilpivirine—CYP3A4—Docetaxel—lung cancer	0.0018	0.00333	CbGbCtD
Rilpivirine—CYP3A4—Doxorubicin—lung cancer	0.00134	0.00248	CbGbCtD
Rilpivirine—Pazopanib—FGFR1—lung cancer	0.00115	0.226	CrCbGaD
Rilpivirine—Pazopanib—FLT1—lung cancer	0.0011	0.216	CrCbGaD
Rilpivirine—Pazopanib—KDR—lung cancer	0.000689	0.136	CrCbGaD
Rilpivirine—Pazopanib—KIT—lung cancer	0.000651	0.128	CrCbGaD
Rilpivirine—Pazopanib—UGT1A1—lung cancer	0.000641	0.126	CrCbGaD
Rilpivirine—Pazopanib—ABCG2—lung cancer	0.00036	0.0708	CrCbGaD
Rilpivirine—Etravirine—ABCB1—lung cancer	0.000344	0.0677	CrCbGaD
Rilpivirine—Creatinine increased—Doxorubicin—lung cancer	0.000168	0.00193	CcSEcCtD
Rilpivirine—Insomnia—Erlotinib—lung cancer	0.000168	0.00193	CcSEcCtD
Rilpivirine—Decreased appetite—Vinblastine—lung cancer	0.000168	0.00193	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.000168	0.00193	CcSEcCtD
Rilpivirine—Urinary tract disorder—Cisplatin—lung cancer	0.000167	0.00192	CcSEcCtD
Rilpivirine—Renal failure—Paclitaxel—lung cancer	0.000167	0.00191	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000167	0.00191	CcSEcCtD
Rilpivirine—Urethral disorder—Cisplatin—lung cancer	0.000166	0.0019	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—lung cancer	0.000165	0.0019	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Docetaxel—lung cancer	0.000164	0.00189	CcSEcCtD
Rilpivirine—Immune system disorder—Gemcitabine—lung cancer	0.000164	0.00188	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Etoposide—lung cancer	0.000164	0.00188	CcSEcCtD
Rilpivirine—Decreased appetite—Topotecan—lung cancer	0.000163	0.00187	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Topotecan—lung cancer	0.000162	0.00186	CcSEcCtD
Rilpivirine—Fatigue—Topotecan—lung cancer	0.000162	0.00186	CcSEcCtD
Rilpivirine—Decreased appetite—Erlotinib—lung cancer	0.000162	0.00185	CcSEcCtD
Rilpivirine—Vomiting—Teniposide—lung cancer	0.000161	0.00185	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Erlotinib—lung cancer	0.00016	0.00184	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Paclitaxel—lung cancer	0.00016	0.00184	CcSEcCtD
Rilpivirine—Fatigue—Erlotinib—lung cancer	0.00016	0.00184	CcSEcCtD
Rilpivirine—Rash—Teniposide—lung cancer	0.00016	0.00183	CcSEcCtD
Rilpivirine—Dermatitis—Teniposide—lung cancer	0.00016	0.00183	CcSEcCtD
Rilpivirine—Infection—Vinorelbine—lung cancer	0.00016	0.00183	CcSEcCtD
Rilpivirine—Headache—Teniposide—lung cancer	0.000159	0.00182	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—lung cancer	0.000158	0.00182	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vinblastine—lung cancer	0.000158	0.00181	CcSEcCtD
Rilpivirine—Nervous system disorder—Vinorelbine—lung cancer	0.000158	0.00181	CcSEcCtD
Rilpivirine—Skin disorder—Vinorelbine—lung cancer	0.000156	0.00179	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Topotecan—lung cancer	0.000154	0.00176	CcSEcCtD
Rilpivirine—Urinary tract disorder—Etoposide—lung cancer	0.000153	0.00176	CcSEcCtD
Rilpivirine—Immune system disorder—Cisplatin—lung cancer	0.000153	0.00176	CcSEcCtD
Rilpivirine—Abdominal pain—Vinblastine—lung cancer	0.000153	0.00175	CcSEcCtD
Rilpivirine—Urethral disorder—Etoposide—lung cancer	0.000152	0.00175	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Erlotinib—lung cancer	0.000152	0.00174	CcSEcCtD
Rilpivirine—Nausea—Teniposide—lung cancer	0.000151	0.00173	CcSEcCtD
Rilpivirine—Urinary tract disorder—Paclitaxel—lung cancer	0.00015	0.00172	CcSEcCtD
Rilpivirine—Pazopanib—ABCB1—lung cancer	0.00015	0.0295	CrCbGaD
Rilpivirine—Urethral disorder—Paclitaxel—lung cancer	0.000149	0.00171	CcSEcCtD
Rilpivirine—Abdominal pain—Topotecan—lung cancer	0.000149	0.0017	CcSEcCtD
Rilpivirine—Malnutrition—Cisplatin—lung cancer	0.000147	0.00169	CcSEcCtD
Rilpivirine—Abdominal pain—Erlotinib—lung cancer	0.000147	0.00169	CcSEcCtD
Rilpivirine—Renal failure—Docetaxel—lung cancer	0.000141	0.00162	CcSEcCtD
Rilpivirine—Immune system disorder—Etoposide—lung cancer	0.00014	0.00161	CcSEcCtD
Rilpivirine—Decreased appetite—Vinorelbine—lung cancer	0.00014	0.0016	CcSEcCtD
Rilpivirine—Asthenia—Vinblastine—lung cancer	0.000139	0.00159	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000139	0.00159	CcSEcCtD
Rilpivirine—Fatigue—Vinorelbine—lung cancer	0.000139	0.00159	CcSEcCtD
Rilpivirine—Immune system disorder—Paclitaxel—lung cancer	0.000137	0.00158	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Docetaxel—lung cancer	0.000136	0.00156	CcSEcCtD
Rilpivirine—Asthenia—Topotecan—lung cancer	0.000135	0.00155	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000134	0.00153	CcSEcCtD
Rilpivirine—Asthenia—Erlotinib—lung cancer	0.000133	0.00153	CcSEcCtD
Rilpivirine—Mental disorder—Paclitaxel—lung cancer	0.000133	0.00153	CcSEcCtD
Rilpivirine—Malnutrition—Paclitaxel—lung cancer	0.000132	0.00152	CcSEcCtD
Rilpivirine—Diarrhoea—Vinblastine—lung cancer	0.000132	0.00152	CcSEcCtD
Rilpivirine—Infection—Irinotecan—lung cancer	0.000132	0.00151	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000131	0.00151	CcSEcCtD
Rilpivirine—Nervous system disorder—Irinotecan—lung cancer	0.00013	0.00149	CcSEcCtD
Rilpivirine—Diarrhoea—Topotecan—lung cancer	0.000129	0.00147	CcSEcCtD
Rilpivirine—Infection—Gemcitabine—lung cancer	0.000128	0.00147	CcSEcCtD
Rilpivirine—Dizziness—Vinblastine—lung cancer	0.000128	0.00147	CcSEcCtD
Rilpivirine—Urinary tract disorder—Docetaxel—lung cancer	0.000127	0.00146	CcSEcCtD
Rilpivirine—Diarrhoea—Erlotinib—lung cancer	0.000127	0.00146	CcSEcCtD
Rilpivirine—Abdominal pain—Vinorelbine—lung cancer	0.000127	0.00146	CcSEcCtD
Rilpivirine—Nervous system disorder—Gemcitabine—lung cancer	0.000127	0.00145	CcSEcCtD
Rilpivirine—Urethral disorder—Docetaxel—lung cancer	0.000126	0.00145	CcSEcCtD
Rilpivirine—Skin disorder—Gemcitabine—lung cancer	0.000125	0.00144	CcSEcCtD
Rilpivirine—Anxiety—Cisplatin—lung cancer	0.000125	0.00144	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000125	0.00143	CcSEcCtD
Rilpivirine—Dizziness—Topotecan—lung cancer	0.000124	0.00143	CcSEcCtD
Rilpivirine—Vomiting—Vinblastine—lung cancer	0.000123	0.00141	CcSEcCtD
Rilpivirine—Dizziness—Erlotinib—lung cancer	0.000123	0.00141	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—lung cancer	0.000122	0.0014	CcSEcCtD
Rilpivirine—Headache—Vinblastine—lung cancer	0.000121	0.00139	CcSEcCtD
Rilpivirine—Insomnia—Irinotecan—lung cancer	0.00012	0.00138	CcSEcCtD
Rilpivirine—Infection—Cisplatin—lung cancer	0.00012	0.00137	CcSEcCtD
Rilpivirine—Vomiting—Topotecan—lung cancer	0.000119	0.00137	CcSEcCtD
Rilpivirine—Rash—Topotecan—lung cancer	0.000118	0.00136	CcSEcCtD
Rilpivirine—Dermatitis—Topotecan—lung cancer	0.000118	0.00136	CcSEcCtD
Rilpivirine—Vomiting—Erlotinib—lung cancer	0.000118	0.00136	CcSEcCtD
Rilpivirine—Nervous system disorder—Cisplatin—lung cancer	0.000118	0.00135	CcSEcCtD
Rilpivirine—Somnolence—Irinotecan—lung cancer	0.000118	0.00135	CcSEcCtD
Rilpivirine—Headache—Topotecan—lung cancer	0.000118	0.00135	CcSEcCtD
Rilpivirine—Rash—Erlotinib—lung cancer	0.000117	0.00134	CcSEcCtD
Rilpivirine—Dermatitis—Erlotinib—lung cancer	0.000117	0.00134	CcSEcCtD
Rilpivirine—Skin disorder—Cisplatin—lung cancer	0.000117	0.00134	CcSEcCtD
Rilpivirine—Insomnia—Gemcitabine—lung cancer	0.000117	0.00134	CcSEcCtD
Rilpivirine—Immune system disorder—Docetaxel—lung cancer	0.000116	0.00134	CcSEcCtD
Rilpivirine—Headache—Erlotinib—lung cancer	0.000116	0.00134	CcSEcCtD
Rilpivirine—Asthenia—Vinorelbine—lung cancer	0.000115	0.00132	CcSEcCtD
Rilpivirine—Decreased appetite—Irinotecan—lung cancer	0.000115	0.00132	CcSEcCtD
Rilpivirine—Nausea—Vinblastine—lung cancer	0.000115	0.00132	CcSEcCtD
Rilpivirine—Somnolence—Gemcitabine—lung cancer	0.000115	0.00132	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000114	0.00131	CcSEcCtD
Rilpivirine—Fatigue—Irinotecan—lung cancer	0.000114	0.00131	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000114	0.00131	CcSEcCtD
Rilpivirine—Mental disorder—Docetaxel—lung cancer	0.000113	0.0013	CcSEcCtD
Rilpivirine—Anxiety—Paclitaxel—lung cancer	0.000112	0.00129	CcSEcCtD
Rilpivirine—Malnutrition—Docetaxel—lung cancer	0.000112	0.00129	CcSEcCtD
Rilpivirine—Decreased appetite—Gemcitabine—lung cancer	0.000112	0.00129	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000112	0.00128	CcSEcCtD
Rilpivirine—Nausea—Topotecan—lung cancer	0.000112	0.00128	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000111	0.00128	CcSEcCtD
Rilpivirine—Abdominal discomfort—Methotrexate—lung cancer	0.000111	0.00128	CcSEcCtD
Rilpivirine—Fatigue—Gemcitabine—lung cancer	0.000111	0.00128	CcSEcCtD
Rilpivirine—Nausea—Erlotinib—lung cancer	0.00011	0.00127	CcSEcCtD
Rilpivirine—Dry mouth—Paclitaxel—lung cancer	0.00011	0.00127	CcSEcCtD
Rilpivirine—Diarrhoea—Vinorelbine—lung cancer	0.00011	0.00126	CcSEcCtD
Rilpivirine—Infection—Etoposide—lung cancer	0.00011	0.00126	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—lung cancer	0.000109	0.00125	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Irinotecan—lung cancer	0.000108	0.00124	CcSEcCtD
Rilpivirine—Infection—Paclitaxel—lung cancer	0.000107	0.00123	CcSEcCtD
Rilpivirine—Skin disorder—Etoposide—lung cancer	0.000107	0.00123	CcSEcCtD
Rilpivirine—Dizziness—Vinorelbine—lung cancer	0.000106	0.00122	CcSEcCtD
Rilpivirine—Nervous system disorder—Paclitaxel—lung cancer	0.000106	0.00122	CcSEcCtD
Rilpivirine—Skin disorder—Paclitaxel—lung cancer	0.000105	0.0012	CcSEcCtD
Rilpivirine—Abdominal pain—Irinotecan—lung cancer	0.000105	0.0012	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000105	0.0012	CcSEcCtD
Rilpivirine—Decreased appetite—Cisplatin—lung cancer	0.000105	0.0012	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000104	0.00119	CcSEcCtD
Rilpivirine—Depression—Methotrexate—lung cancer	0.000103	0.00118	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000103	0.00118	CcSEcCtD
Rilpivirine—Vomiting—Vinorelbine—lung cancer	0.000102	0.00117	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—lung cancer	0.000102	0.00117	CcSEcCtD
Rilpivirine—Rash—Vinorelbine—lung cancer	0.000101	0.00116	CcSEcCtD
Rilpivirine—Dermatitis—Vinorelbine—lung cancer	0.000101	0.00116	CcSEcCtD
Rilpivirine—Headache—Vinorelbine—lung cancer	0.000101	0.00115	CcSEcCtD
Rilpivirine—Somnolence—Etoposide—lung cancer	9.8e-05	0.00112	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—lung cancer	9.79e-05	0.00112	CcSEcCtD
Rilpivirine—Insomnia—Paclitaxel—lung cancer	9.78e-05	0.00112	CcSEcCtD
Rilpivirine—Somnolence—Paclitaxel—lung cancer	9.61e-05	0.0011	CcSEcCtD
Rilpivirine—Decreased appetite—Etoposide—lung cancer	9.58e-05	0.0011	CcSEcCtD
Rilpivirine—Nausea—Vinorelbine—lung cancer	9.55e-05	0.0011	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Etoposide—lung cancer	9.52e-05	0.00109	CcSEcCtD
Rilpivirine—Asthenia—Irinotecan—lung cancer	9.51e-05	0.00109	CcSEcCtD
Rilpivirine—Fatigue—Etoposide—lung cancer	9.51e-05	0.00109	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.49e-05	0.00109	CcSEcCtD
Rilpivirine—Decreased appetite—Paclitaxel—lung cancer	9.4e-05	0.00108	CcSEcCtD
Rilpivirine—Dry mouth—Docetaxel—lung cancer	9.35e-05	0.00107	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Paclitaxel—lung cancer	9.33e-05	0.00107	CcSEcCtD
Rilpivirine—Fatigue—Paclitaxel—lung cancer	9.32e-05	0.00107	CcSEcCtD
Rilpivirine—Asthenia—Gemcitabine—lung cancer	9.26e-05	0.00106	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—lung cancer	9.18e-05	0.00105	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—lung cancer	9.11e-05	0.00105	CcSEcCtD
Rilpivirine—Infection—Docetaxel—lung cancer	9.1e-05	0.00104	CcSEcCtD
Rilpivirine—Diarrhoea—Irinotecan—lung cancer	9.07e-05	0.00104	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Etoposide—lung cancer	9.02e-05	0.00103	CcSEcCtD
Rilpivirine—Nervous system disorder—Docetaxel—lung cancer	8.99e-05	0.00103	CcSEcCtD
Rilpivirine—Skin disorder—Docetaxel—lung cancer	8.9e-05	0.00102	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Paclitaxel—lung cancer	8.84e-05	0.00101	CcSEcCtD
Rilpivirine—Diarrhoea—Gemcitabine—lung cancer	8.83e-05	0.00101	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—lung cancer	8.81e-05	0.00101	CcSEcCtD
Rilpivirine—Dizziness—Irinotecan—lung cancer	8.77e-05	0.00101	CcSEcCtD
Rilpivirine—Abdominal pain—Etoposide—lung cancer	8.72e-05	0.001	CcSEcCtD
Rilpivirine—Asthenia—Cisplatin—lung cancer	8.64e-05	0.00099	CcSEcCtD
Rilpivirine—Abdominal pain—Paclitaxel—lung cancer	8.55e-05	0.00098	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—lung cancer	8.48e-05	0.000973	CcSEcCtD
Rilpivirine—Vomiting—Irinotecan—lung cancer	8.43e-05	0.000967	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—lung cancer	8.4e-05	0.000963	CcSEcCtD
Rilpivirine—Rash—Irinotecan—lung cancer	8.36e-05	0.000959	CcSEcCtD
Rilpivirine—Dermatitis—Irinotecan—lung cancer	8.35e-05	0.000958	CcSEcCtD
Rilpivirine—Headache—Irinotecan—lung cancer	8.3e-05	0.000953	CcSEcCtD
Rilpivirine—Insomnia—Docetaxel—lung cancer	8.29e-05	0.000951	CcSEcCtD
Rilpivirine—Diarrhoea—Cisplatin—lung cancer	8.23e-05	0.000945	CcSEcCtD
Rilpivirine—Vomiting—Gemcitabine—lung cancer	8.21e-05	0.000942	CcSEcCtD
Rilpivirine—Somnolence—Docetaxel—lung cancer	8.15e-05	0.000934	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—lung cancer	8.14e-05	0.000934	CcSEcCtD
Rilpivirine—Rash—Gemcitabine—lung cancer	8.14e-05	0.000934	CcSEcCtD
Rilpivirine—Dermatitis—Gemcitabine—lung cancer	8.13e-05	0.000933	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—lung cancer	8.09e-05	0.000928	CcSEcCtD
Rilpivirine—Headache—Gemcitabine—lung cancer	8.09e-05	0.000928	CcSEcCtD
Rilpivirine—Decreased appetite—Docetaxel—lung cancer	7.97e-05	0.000914	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—lung cancer	7.95e-05	0.000912	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Docetaxel—lung cancer	7.91e-05	0.000907	CcSEcCtD
Rilpivirine—Asthenia—Etoposide—lung cancer	7.91e-05	0.000907	CcSEcCtD
Rilpivirine—Fatigue—Docetaxel—lung cancer	7.9e-05	0.000906	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—lung cancer	7.89e-05	0.000905	CcSEcCtD
Rilpivirine—Nausea—Irinotecan—lung cancer	7.87e-05	0.000903	CcSEcCtD
Rilpivirine—Asthenia—Paclitaxel—lung cancer	7.76e-05	0.00089	CcSEcCtD
Rilpivirine—Nausea—Gemcitabine—lung cancer	7.67e-05	0.00088	CcSEcCtD
Rilpivirine—Vomiting—Cisplatin—lung cancer	7.65e-05	0.000878	CcSEcCtD
Rilpivirine—Rash—Cisplatin—lung cancer	7.59e-05	0.00087	CcSEcCtD
Rilpivirine—Dermatitis—Cisplatin—lung cancer	7.58e-05	0.00087	CcSEcCtD
Rilpivirine—Diarrhoea—Etoposide—lung cancer	7.54e-05	0.000865	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Docetaxel—lung cancer	7.49e-05	0.000859	CcSEcCtD
Rilpivirine—Diarrhoea—Paclitaxel—lung cancer	7.4e-05	0.000848	CcSEcCtD
Rilpivirine—Dizziness—Etoposide—lung cancer	7.29e-05	0.000836	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—lung cancer	7.27e-05	0.000834	CcSEcCtD
Rilpivirine—Abdominal pain—Docetaxel—lung cancer	7.24e-05	0.000831	CcSEcCtD
Rilpivirine—Dizziness—Paclitaxel—lung cancer	7.15e-05	0.00082	CcSEcCtD
Rilpivirine—Nausea—Cisplatin—lung cancer	7.15e-05	0.00082	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—lung cancer	7.05e-05	0.000809	CcSEcCtD
Rilpivirine—Vomiting—Etoposide—lung cancer	7.01e-05	0.000804	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—lung cancer	7.01e-05	0.000804	CcSEcCtD
Rilpivirine—Rash—Etoposide—lung cancer	6.95e-05	0.000797	CcSEcCtD
Rilpivirine—Dermatitis—Etoposide—lung cancer	6.95e-05	0.000797	CcSEcCtD
Rilpivirine—Headache—Etoposide—lung cancer	6.91e-05	0.000792	CcSEcCtD
Rilpivirine—Vomiting—Paclitaxel—lung cancer	6.87e-05	0.000788	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.84e-05	0.000785	CcSEcCtD
Rilpivirine—Rash—Paclitaxel—lung cancer	6.82e-05	0.000782	CcSEcCtD
Rilpivirine—Dermatitis—Paclitaxel—lung cancer	6.81e-05	0.000781	CcSEcCtD
Rilpivirine—Headache—Paclitaxel—lung cancer	6.77e-05	0.000777	CcSEcCtD
Rilpivirine—Asthenia—Docetaxel—lung cancer	6.57e-05	0.000754	CcSEcCtD
Rilpivirine—Infection—Methotrexate—lung cancer	6.56e-05	0.000753	CcSEcCtD
Rilpivirine—Nausea—Etoposide—lung cancer	6.55e-05	0.000751	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—lung cancer	6.48e-05	0.000743	CcSEcCtD
Rilpivirine—Nausea—Paclitaxel—lung cancer	6.42e-05	0.000737	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—lung cancer	6.42e-05	0.000736	CcSEcCtD
Rilpivirine—Diarrhoea—Docetaxel—lung cancer	6.27e-05	0.000719	CcSEcCtD
Rilpivirine—Dizziness—Docetaxel—lung cancer	6.06e-05	0.000695	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—lung cancer	5.97e-05	0.000685	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—lung cancer	5.95e-05	0.000682	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.92e-05	0.00068	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—lung cancer	5.87e-05	0.000673	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—lung cancer	5.83e-05	0.000669	CcSEcCtD
Rilpivirine—Vomiting—Docetaxel—lung cancer	5.83e-05	0.000668	CcSEcCtD
Rilpivirine—Rash—Docetaxel—lung cancer	5.78e-05	0.000663	CcSEcCtD
Rilpivirine—Dermatitis—Docetaxel—lung cancer	5.77e-05	0.000662	CcSEcCtD
Rilpivirine—Decreased appetite—Methotrexate—lung cancer	5.74e-05	0.000659	CcSEcCtD
Rilpivirine—Headache—Docetaxel—lung cancer	5.74e-05	0.000658	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—lung cancer	5.7e-05	0.000654	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—lung cancer	5.69e-05	0.000653	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—lung cancer	5.68e-05	0.000652	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—lung cancer	5.61e-05	0.000643	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—lung cancer	5.55e-05	0.000637	CcSEcCtD
Rilpivirine—Nausea—Docetaxel—lung cancer	5.44e-05	0.000624	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—lung cancer	5.4e-05	0.000619	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—lung cancer	5.22e-05	0.000599	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—lung cancer	5.17e-05	0.000593	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—lung cancer	5.08e-05	0.000583	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—lung cancer	4.97e-05	0.00057	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—lung cancer	4.94e-05	0.000566	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—lung cancer	4.93e-05	0.000566	CcSEcCtD
Rilpivirine—Asthenia—Methotrexate—lung cancer	4.74e-05	0.000544	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—lung cancer	4.68e-05	0.000536	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—lung cancer	4.52e-05	0.000519	CcSEcCtD
Rilpivirine—Diarrhoea—Methotrexate—lung cancer	4.52e-05	0.000518	CcSEcCtD
Rilpivirine—Dizziness—Methotrexate—lung cancer	4.37e-05	0.000501	CcSEcCtD
Rilpivirine—Vomiting—Methotrexate—lung cancer	4.2e-05	0.000482	CcSEcCtD
Rilpivirine—Rash—Methotrexate—lung cancer	4.16e-05	0.000478	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—lung cancer	4.16e-05	0.000477	CcSEcCtD
Rilpivirine—Headache—Methotrexate—lung cancer	4.14e-05	0.000475	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—lung cancer	4.1e-05	0.000471	CcSEcCtD
Rilpivirine—Nausea—Methotrexate—lung cancer	3.92e-05	0.00045	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—lung cancer	3.91e-05	0.000449	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—lung cancer	3.78e-05	0.000434	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—lung cancer	3.64e-05	0.000417	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—lung cancer	3.61e-05	0.000414	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—lung cancer	3.6e-05	0.000413	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—lung cancer	3.58e-05	0.000411	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—lung cancer	3.4e-05	0.00039	CcSEcCtD
Rilpivirine—ABCG2—Metabolism—ABCB1—lung cancer	7.02e-06	0.000107	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—UGT1A1—lung cancer	7.01e-06	0.000107	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—RRM1—lung cancer	7e-06	0.000107	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTA3—lung cancer	7e-06	0.000107	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP1A1—lung cancer	6.97e-06	0.000106	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GNG11—lung cancer	6.92e-06	0.000105	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ERCC2—lung cancer	6.92e-06	0.000105	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TYMS—lung cancer	6.89e-06	0.000105	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.89e-06	0.000105	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	6.87e-06	0.000105	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTM1—lung cancer	6.81e-06	0.000104	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GNG11—lung cancer	6.76e-06	0.000103	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM2—lung cancer	6.7e-06	0.000102	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CNDP2—lung cancer	6.7e-06	0.000102	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	6.64e-06	0.000101	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALDOA—lung cancer	6.59e-06	0.0001	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP2E1—lung cancer	6.59e-06	0.0001	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—B4GALT5—lung cancer	6.58e-06	0.0001	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTMR3—lung cancer	6.52e-06	9.93e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NQO1—lung cancer	6.51e-06	9.92e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP1A1—lung cancer	6.46e-06	9.83e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALDOA—lung cancer	6.44e-06	9.8e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ERCC2—lung cancer	6.4e-06	9.75e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTA4—lung cancer	6.4e-06	9.75e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NCOA3—lung cancer	6.4e-06	9.75e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	6.39e-06	9.74e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PGAM1—lung cancer	6.35e-06	9.68e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.29e-06	9.58e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.26e-06	9.53e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NCOA3—lung cancer	6.25e-06	9.52e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTA2—lung cancer	6.24e-06	9.5e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CB—lung cancer	6.23e-06	9.49e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ADCY1—lung cancer	6.23e-06	9.49e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCG2—lung cancer	6.23e-06	9.49e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—lung cancer	6.17e-06	9.4e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ENO2—lung cancer	6.11e-06	9.3e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HPGDS—lung cancer	6.11e-06	9.3e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ADCY1—lung cancer	6.08e-06	9.26e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ABCG2—lung cancer	6.08e-06	9.26e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPP2R1B—lung cancer	6.07e-06	9.24e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP2A7—lung cancer	6.06e-06	9.23e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTA1—lung cancer	6.02e-06	9.17e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.99e-06	9.12e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOA1—lung cancer	5.98e-06	9.11e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ENO2—lung cancer	5.96e-06	9.08e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HPGDS—lung cancer	5.96e-06	9.08e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCC3—lung cancer	5.95e-06	9.07e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SDC4—lung cancer	5.93e-06	9.03e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPP2R1B—lung cancer	5.92e-06	9.02e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTT1—lung cancer	5.92e-06	9.02e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—STK11—lung cancer	5.87e-06	8.94e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GCLC—lung cancer	5.85e-06	8.92e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP2A6—lung cancer	5.85e-06	8.92e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.83e-06	8.88e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTT1—lung cancer	5.78e-06	8.81e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKR1C1—lung cancer	5.76e-06	8.78e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.73e-06	8.73e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GCLC—lung cancer	5.71e-06	8.7e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP2A6—lung cancer	5.71e-06	8.7e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.61e-06	8.55e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—UGT1A1—lung cancer	5.6e-06	8.52e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ENO1—lung cancer	5.55e-06	8.45e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOA1—lung cancer	5.54e-06	8.44e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.53e-06	8.42e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CG—lung cancer	5.46e-06	8.32e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.46e-06	8.32e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTP1—lung cancer	5.43e-06	8.28e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ENO1—lung cancer	5.42e-06	8.25e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.41e-06	8.24e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—RRM1—lung cancer	5.4e-06	8.23e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTA3—lung cancer	5.4e-06	8.23e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GNG11—lung cancer	5.4e-06	8.22e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—lung cancer	5.38e-06	8.2e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.37e-06	8.18e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CAT—lung cancer	5.29e-06	8.05e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—POMC—lung cancer	5.2e-06	7.92e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCB1—lung cancer	5.14e-06	7.83e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALDOA—lung cancer	5.14e-06	7.83e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—EP300—lung cancer	5.13e-06	7.82e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—B4GALT5—lung cancer	5.08e-06	7.74e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.07e-06	7.72e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CREBBP—lung cancer	5.06e-06	7.71e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CG—lung cancer	5.06e-06	7.7e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TYMS—lung cancer	5.05e-06	7.69e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—lung cancer	4.99e-06	7.6e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NCOA3—lung cancer	4.99e-06	7.6e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP2E1—lung cancer	4.98e-06	7.58e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTA4—lung cancer	4.94e-06	7.53e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NQO1—lung cancer	4.92e-06	7.5e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.9e-06	7.47e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP2E1—lung cancer	4.86e-06	7.4e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ADCY1—lung cancer	4.85e-06	7.39e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCG2—lung cancer	4.85e-06	7.39e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.82e-06	7.34e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTA2—lung cancer	4.81e-06	7.33e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—POMC—lung cancer	4.81e-06	7.33e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NQO1—lung cancer	4.8e-06	7.32e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CD—lung cancer	4.8e-06	7.31e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.78e-06	7.27e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HPGDS—lung cancer	4.76e-06	7.25e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ENO2—lung cancer	4.76e-06	7.25e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—lung cancer	4.74e-06	7.22e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP1A1—lung cancer	4.73e-06	7.21e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.73e-06	7.2e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ERCC2—lung cancer	4.69e-06	7.15e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CREBBP—lung cancer	4.69e-06	7.14e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.66e-06	7.11e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTA1—lung cancer	4.65e-06	7.08e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTT1—lung cancer	4.61e-06	7.03e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCC3—lung cancer	4.59e-06	7e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.58e-06	6.98e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP2A6—lung cancer	4.56e-06	6.95e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GCLC—lung cancer	4.56e-06	6.95e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.54e-06	6.92e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKR1C1—lung cancer	4.45e-06	6.78e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CD—lung cancer	4.45e-06	6.77e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—STK11—lung cancer	4.44e-06	6.76e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—lung cancer	4.39e-06	6.69e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—STK11—lung cancer	4.33e-06	6.6e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ENO1—lung cancer	4.32e-06	6.59e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—UGT1A1—lung cancer	4.32e-06	6.58e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.31e-06	6.56e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.25e-06	6.48e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CB—lung cancer	4.18e-06	6.37e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.16e-06	6.34e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GNG11—lung cancer	4.16e-06	6.34e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—lung cancer	4.15e-06	6.32e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTP1—lung cancer	4.11e-06	6.25e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOA1—lung cancer	4.06e-06	6.19e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTP1—lung cancer	4.01e-06	6.1e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CAT—lung cancer	3.99e-06	6.09e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.97e-06	6.05e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALDOA—lung cancer	3.96e-06	6.04e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CAT—lung cancer	3.9e-06	5.94e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCB1—lung cancer	3.89e-06	5.92e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP2E1—lung cancer	3.88e-06	5.91e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CB—lung cancer	3.87e-06	5.9e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NCOA3—lung cancer	3.85e-06	5.86e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—lung cancer	3.84e-06	5.85e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NQO1—lung cancer	3.84e-06	5.84e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TYMS—lung cancer	3.82e-06	5.81e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CA—lung cancer	3.8e-06	5.78e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—lung cancer	3.77e-06	5.75e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.76e-06	5.72e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ADCY1—lung cancer	3.74e-06	5.7e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCG2—lung cancer	3.74e-06	5.7e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TYMS—lung cancer	3.72e-06	5.67e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.72e-06	5.67e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CG—lung cancer	3.71e-06	5.65e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—lung cancer	3.68e-06	5.61e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HPGDS—lung cancer	3.67e-06	5.59e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ENO2—lung cancer	3.67e-06	5.59e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.65e-06	5.56e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—lung cancer	3.62e-06	5.51e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP1A1—lung cancer	3.58e-06	5.45e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTT1—lung cancer	3.56e-06	5.43e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ERCC2—lung cancer	3.55e-06	5.4e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—POMC—lung cancer	3.53e-06	5.38e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GCLC—lung cancer	3.52e-06	5.36e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP2A6—lung cancer	3.52e-06	5.36e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP1A1—lung cancer	3.49e-06	5.32e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ERCC2—lung cancer	3.46e-06	5.27e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—STK11—lung cancer	3.46e-06	5.27e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—EP300—lung cancer	3.45e-06	5.25e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CREBBP—lung cancer	3.44e-06	5.24e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—lung cancer	3.35e-06	5.1e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ENO1—lung cancer	3.34e-06	5.08e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CD—lung cancer	3.26e-06	4.96e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.24e-06	4.94e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—lung cancer	3.22e-06	4.9e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTP1—lung cancer	3.2e-06	4.87e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—EP300—lung cancer	3.19e-06	4.86e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CAT—lung cancer	3.11e-06	4.74e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—lung cancer	3.1e-06	4.73e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.09e-06	4.71e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOA1—lung cancer	3.07e-06	4.67e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCB1—lung cancer	3.03e-06	4.61e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOA1—lung cancer	2.99e-06	4.56e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP2E1—lung cancer	2.99e-06	4.56e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TYMS—lung cancer	2.97e-06	4.53e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NQO1—lung cancer	2.96e-06	4.51e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—lung cancer	2.94e-06	4.48e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.94e-06	4.48e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CB—lung cancer	2.84e-06	4.33e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—lung cancer	2.81e-06	4.29e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CG—lung cancer	2.8e-06	4.27e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP1A1—lung cancer	2.79e-06	4.24e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ERCC2—lung cancer	2.76e-06	4.21e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CG—lung cancer	2.73e-06	4.16e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—STK11—lung cancer	2.67e-06	4.06e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—POMC—lung cancer	2.67e-06	4.06e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—POMC—lung cancer	2.6e-06	3.96e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CREBBP—lung cancer	2.6e-06	3.96e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CA—lung cancer	2.55e-06	3.89e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CREBBP—lung cancer	2.53e-06	3.86e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTP1—lung cancer	2.47e-06	3.76e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CD—lung cancer	2.46e-06	3.75e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—lung cancer	2.45e-06	3.74e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—lung cancer	2.43e-06	3.7e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CD—lung cancer	2.4e-06	3.66e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CAT—lung cancer	2.4e-06	3.66e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOA1—lung cancer	2.39e-06	3.64e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—lung cancer	2.37e-06	3.61e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CA—lung cancer	2.36e-06	3.6e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—EP300—lung cancer	2.34e-06	3.57e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCB1—lung cancer	2.34e-06	3.56e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TYMS—lung cancer	2.29e-06	3.5e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.29e-06	3.49e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—lung cancer	2.27e-06	3.46e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CG—lung cancer	2.18e-06	3.32e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.15e-06	3.28e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CB—lung cancer	2.15e-06	3.27e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ERCC2—lung cancer	2.13e-06	3.25e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—lung cancer	2.13e-06	3.24e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CB—lung cancer	2.09e-06	3.19e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—lung cancer	2.08e-06	3.17e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—POMC—lung cancer	2.08e-06	3.16e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—lung cancer	2.08e-06	3.16e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CREBBP—lung cancer	2.02e-06	3.08e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—lung cancer	1.93e-06	2.94e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.92e-06	2.92e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—lung cancer	1.89e-06	2.89e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—lung cancer	1.85e-06	2.83e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOA1—lung cancer	1.85e-06	2.81e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—lung cancer	1.81e-06	2.76e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—EP300—lung cancer	1.77e-06	2.69e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CA—lung cancer	1.73e-06	2.64e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—EP300—lung cancer	1.73e-06	2.63e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.68e-06	2.57e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.67e-06	2.55e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—lung cancer	1.66e-06	2.52e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—POMC—lung cancer	1.6e-06	2.44e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CREBBP—lung cancer	1.56e-06	2.38e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.48e-06	2.26e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—lung cancer	1.46e-06	2.23e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—lung cancer	1.45e-06	2.2e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—lung cancer	1.41e-06	2.15e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—EP300—lung cancer	1.38e-06	2.1e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.31e-06	1.99e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.29e-06	1.97e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—lung cancer	1.28e-06	1.95e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CA—lung cancer	1.28e-06	1.95e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—lung cancer	1.12e-06	1.7e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—lung cancer	1.07e-06	1.63e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—EP300—lung cancer	1.06e-06	1.62e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—lung cancer	1.04e-06	1.59e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.02e-06	1.55e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—lung cancer	8.33e-07	1.27e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CA—lung cancer	7.87e-07	1.2e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—lung cancer	6.43e-07	9.79e-06	CbGpPWpGaD
